MYGN · Myriad Genetics Inc · Documents
$6.65
+0.02 (+0.30%)
At close · Oct 29
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$634.16M
Shares
95.65M
Volume · Oct 29
453.79K
Avg daily vol (3M)
2.63M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2021-05-03 | — | |
| DEF 14A | — | 2021-04-15 | 2021-06-03 | |
| DEFA14A | — | 2021-04-15 | — | |
| NT 10-K | — | 2021-03-02 | 2020-12-31 | |
| 8-K | — | 2021-02-23 | 2021-02-22 | |
| 8-K | — | 2020-12-07 | 2020-12-04 | |
| 8-K | — | 2020-11-09 | — | |
| 10-Q | — | 2020-11-09 | 2020-09-30 | |
| 8-K | — | 2020-10-15 | 2020-10-09 | |
| DEFA14A | — | 2020-10-15 | — | |
| DEF 14A | — | 2020-10-15 | 2020-12-04 | |
| DEFA14A | — | 2020-10-15 | — | |
| 8-K | — | 2020-10-05 | 2020-09-29 | |
| 8-K | — | 2020-09-24 | 2020-09-21 | |
| 8-K | — | 2020-09-10 | 2020-09-09 | |
| 8-K | — | 2020-08-14 | 2020-08-13 | |
| 8-K | — | 2020-08-13 | — | |
| 10-K | — | 2020-08-13 | 2020-06-30 | |
| 8-K | — | 2020-08-13 | — | |
| 8-K | — | 2020-07-22 | 2020-07-21 | |
| 8-K | — | 2020-05-28 | 2020-05-27 | |
| 8-K | — | 2020-05-12 | 2020-05-06 | |
| 10-Q | — | 2020-05-06 | 2020-03-31 | |
| 8-K | — | 2020-05-05 | — | |
| 8-K | — | 2020-04-08 | — | |
| 8-K | — | 2020-03-23 | 2020-03-21 | |
| 10-Q | — | 2020-02-07 | 2019-12-31 | |
| 8-K/A | — | 2020-02-07 | 2020-02-06 | |
| 8-K | — | 2020-02-06 | — | |
| 8-K | — | 2020-02-06 | — |
Showing 101–130 of 130 filings
Key facts
CIK
899923
CUSIP
62855J104
13F (30d)
25 filings
25 filers
Visit website
Investor relations